Clinical Research Directory
Browse clinical research sites, groups, and studies.
Perioperative Management of Factor Xa Inhibitors
Sponsor: Seoul National University Hospital
Summary
This study aims to analyze the safety and effectiveness of the discontinuation/resumption protocol of factor Xa inhibitors before and after invasive procedures/surgeries in non-valvular atrial fibrillation patients who are at risk of minor bleeding in actual clinical settings
Official title: Effectiveness and Safety of PERIoperative Factor Xa Inhibitor Discontinuation in Patients with Atrial Fibrillation Who Undergoing Minor Bleeding Risk Elective Procedure or Surgery: a Prospective, Multicenter, Noninterventional Study (PERIXa Study)
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2500
Start Date
2020-08-04
Completion Date
2025-12-31
Last Updated
2025-01-07
Healthy Volunteers
No
Interventions
Factor Xa Inhibitor
Hold and resume factor Xa inhibitor during perioperative/periprocedural period according to the predefined protocol.
Locations (1)
Seoul National university Hostpital
Seoul, Jongno-gu, South Korea